Sartorius Stedim Biotech SA - Company Profile
Powered by
All the data and insights you need on Sartorius Stedim Biotech SA in one report.
$295
- Save hours of research time and resources with
our up-to-date Sartorius Stedim Biotech SA Strategy Report
- Understand Sartorius Stedim Biotech SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Sartorius Stedim Biotech SA’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
08 Aug 2022 | Sartorius Stedim Biotech Acquires Albumedix | Acquisition |
Sartorius Stedim Biotech SA
|
Albumedix Ltd
|
29 Jul 2021 | Sartorius Stedim Biotech Acquires Xell | Acquisition |
Sartorius Stedim Biotech SA
|
Xell AG
|
02 Jul 2021 | Sartorius Acquires 51% Stake in CellGenix | Acquisition |
Sartorius Stedim Biotech SA
|
CellGenix GmbH
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer